Search results
Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past.
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
Janssen Inc., a pharmaceutical company of Johnson & Johnson, has been an innovator in the Canadian healthcare... Healthcare Policy Janssen believes collaboration among government agencies, public and private payers, healthcare professionals, the...
Our Products. To download the Janssen Terms of Sale and Returned Goods Policy, click here.
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 ...
The Janssen Pharmaceutical Companies of Johnson & Johnson | 1,025,388 followers on LinkedIn. At Janssen, we never stop working toward a future where disease is a thing of the past.
Mar 3, 2021 · Learn more about the process of making a vaccine, and the ways Johnson & Johnson was able to partner and collaborate to manufacture the Janssen COVID-19 Vaccine.
